Physician profile
Gary E Pearlstein
NPI 1366476442
$1,744.02
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $21.78 · 2021: $240 · 2022: $74.38 · 2023: $1,176 · 2024: $19.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $942 · Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $941.67 |
| Food and Beverage | $253.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $1,176.64 | 2022-2023 | V.A.C. Veraflo, Prevena, Promogran Prisma |
| Intuitive Surgical, INC. | $163.82 | 2019-2021 | |
| Ethicon US, LLC | $132.48 | 2019-2021 | |
| Integra Lifesciences Corporation | $64.86 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Antares Pharma, INC. | $41.58 | 2021 | |
| Heron Therapeutics, INC. | $37.24 | 2021-2022 | |
| Covidien LP | $28.96 | 2019 | |
| Abbott Laboratories | $25.79 | 2019 | |
| Kerecis Limited | $20.70 | 2021 | |
| Myovant Sciences INC. | $19.80 | 2022 | |
| Braintree Laboratories, INC. | $18.60 | 2023 | Sutab, Suflave |
| Ucb, INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Pearlstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.